论文部分内容阅读
【化学名】N,N′—双[3—(3′,4′,5′—三甲氧基苯酰氧基)丙基]全氢化—1,4—二氮杂(?)盐酸盐单水化合物。【结构式】【作用特点】本品是一种新型克冠酸类抗缺血性心脏病药物,通过抑制体内腺苷分解代谢而具有明显、持久的选择性冠脉扩张作用。并有降低冠脉阻力,促进冠脉侧枝形成,改善心肌血液供应,抑制血小板凝集等作用。经同位素研究证明,长期服用本品不会引起体内蓄积。【适应症】冠心病心绞痛,心衰,心肌梗塞恢复期等。【禁忌症】急性心肌梗塞病人忌用。
【Chemical Name】 N, N’-bis [3- (3 ’, 4’, 5’-trimethoxybenzoyl) propyl] perhydro-1,4-diazepine hydrochloride Monohydrate. 【Structure】 【Features】 This product is a new type of anti-coronary heart disease medicine, through the inhibition of adenosine catabolism in vivo and has obvious, long-lasting selective coronary dilatation. And reduce coronary resistance, promote coronary collateral formation, improve myocardial blood supply, inhibition of platelet aggregation and so on. The isotope studies have shown that long-term use of this product does not cause accumulation in the body. Indications coronary heart disease angina, heart failure, myocardial infarction recovery period. [Contraindications] Acute myocardial infarction patients hanged.